DCAT's 2018 Study: Examining Current and Future Alignment of the Pharma Customer-Supplier Relationship

Gain valuable insight from DCAT’s new benchmarking study, Examining the Current and Future Alignment of the Pharma Customer–Supplier Relationship, which evaluates the current and near-future imperatives for both pharma companies and pharma service providers/suppliers.

The study, developed for and provided exclusively to DCAT member companies, surveyed executives from pharmaceutical companies, CDMOs, CMOs, and suppliers to identify areas of alignment and misalignment and opportunities for optimizing strategic relationships.

Learn what is driving the business of pharmaceutical development and manufacturing by gaining answers to these all-important questions:

What capabilities are pharma companies seeking now and in the near term?

What specialized services do pharma companies need?

Are pharma companies’ needs in line with suppliers’ capabilities sets?

What are pharma companies’ expectations for suppliers’ in key performance indicators?

Tune into the DCAT Benchmarking Webinar on Wednesday, January 16th, 11:00 am - 11:30 am (EST)Complimentary for DCAT Member CompaniesClick here to register for the live webinar and/or on-demand viewing

DCAT Benchmarking is a complimentary service for DCAT member companies. To access the study, you must be logged-in to DCAT Connect. Trouble logging in? Contact Erin Sanders at esanders@dcat.org or +1-609-208-1888 ext. 7001 or review the instructions here.

DCAT's 2017 Study: Value-Based Metrics

Released in November, 2017, Value Based Metrics examined the practices and key metrics used by both pharmaceutical companies and suppliers to measure the benefits of value-creation activities in the supply of direct materials used in pharmaceutical/biopharmaceutical development and manufacturing.

DCAT's 2016 Study: Value Creation in Pharmaceutical Procurement

Released in April, 2016, Value Creation in Pharmaceutical Procurement examined Procurement’s involvement in value creation, including its level of vertical and horizontal alignment and influence with its internal customers (senior executive management and business units) as well as with its suppliers for achieving corporate and business goals.

With 47 benchmarks assessed, this report serves as an important way to evaluate how your company stands with your peers in the industry.

DCAT Benchmarking is a complimentary service for DCAT member companies. To access the study, you must be logged-in to DCAT Connect. Trouble logging in? Contact Erin Sanders at esanders@dcat.org or +1-609-208-1888 ext. 7001.

About DCAT Benchmarking

DCAT Benchmarking is a member service delivering in-depth studies examining the crucial issues impacting the pharmaceutical manufacturing value chain. It is a valuable way for learning of best practices and key metrics for companies engaged in pharmaceutical development and manufacturing.

DCAT Benchmarking studies are developed by the DCAT Research & Benchmarking Task Force, composed of member representatives from diverse industry backgrounds and company experience, to identify the topics of greatest interest for DCAT member companies.

Using objective research methods, DCAT Benchmarking studies provide targeted insight for companies engaged in pharmaceutical development and manufacturing in key functional areas, including sourcing, procurement, supply management, and project management.

The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.

Our Sites use cookies and similar technologies for essential site purposes to allow you to use our site and to allow us to provide essential site-related services to you. Find out more about how we use cookies by visiting our Privacy Policy.
By continuing to use our site, you acknowledge our cookies policy.